Bodnar R J, Kramer E, Simone D A, Kirchgessner A L, Scalisi J
Int J Neurosci. 1983 Nov;21(3-4):225-36. doi: 10.3109/00207458308986140.
Injection of 2-deoxy-D-glucose (2DG) elicits both analgesic and hyperphagic responses in rats. While pituitary dysfunction, decreased dopamine availability, or neonatal monosodium glutamate treatment decreases 2DG hyperphagia, they increase 2DG analgesia. In contrast, 2-DG analgesia alone is decreased by repeated 2-DG injections, while 2-DG hyperphagia alone is decreased following naloxone pretreatment. The present four experiments examined further mechanisms subserving these two induced responses. In the first experiment, rats were deprived of food for 6 h following 2-DG (600 mg/kg). While 2-DG hyperphagia persisted in the absence of glucoprivation, 2-DG analgesia failed to occur after this delay. In the second experiment, acute exposure to inescapable foot shock (4 mA, 0.5 s/5 s for 1 h) preceded administration of 2-DG (600 mg/kg). While 2-DG hyperphagia was eliminated by this procedure, 2-DG analgesia was significantly potentiated. In the third experiment, repeated morphine (10 mg/kg) injections over 14 days eliminated 2-DG analgesia on the fifteenth day, but failed to affect 2-DG hyperphagia. In the fourth experiment, lesions placed in either the lateral hypothalamus or zona incerta decreased 2-DG hyperphagia, but failed to affect 2-DG analgesia. These results are discussed in terms of common and dissociative mechanisms mediating both responses.
注射2-脱氧-D-葡萄糖(2DG)会在大鼠身上引发镇痛和摄食亢进反应。虽然垂体功能障碍、多巴胺可用性降低或新生期谷氨酸钠处理会降低2DG引起的摄食亢进,但却会增强2DG的镇痛作用。相反,单独的2DG镇痛作用会因重复注射2DG而减弱,而单独的2DG摄食亢进在纳洛酮预处理后会减弱。目前的四个实验进一步研究了介导这两种诱导反应的机制。在第一个实验中,给大鼠注射2DG(600毫克/千克)后禁食6小时。虽然在没有低血糖的情况下2DG引起的摄食亢进持续存在,但延迟后2DG的镇痛作用并未出现。在第二个实验中,在注射2DG(600毫克/千克)之前,让大鼠急性暴露于不可逃避的足部电击(4毫安,0.5秒/5秒,持续1小时)。虽然这种处理消除了2DG引起的摄食亢进,但2DG的镇痛作用却显著增强。在第三个实验中,在14天内重复注射吗啡(10毫克/千克),在第15天消除了2DG的镇痛作用,但未影响2DG引起的摄食亢进。在第四个实验中,损毁下丘脑外侧区或未定带会降低2DG引起的摄食亢进,但未影响2DG的镇痛作用。本文根据介导这两种反应的共同和分离机制对这些结果进行了讨论。